Home
ONCT
ONCT News

Latest Oncternal Therapeutics Inc. (ONCT) News on November 16, 2024

Oncternal Therapeutics Announces Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire

25 days ago

Oncternal Therapeutics Announces Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives

GlobeNewswire

2 months ago

Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives

Oncternal Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Oncternal Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results

Oncternal Announces Enrollment Completed and Dosing Initiated for Sixth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire

4 months ago

Oncternal Announces Enrollment Completed and Dosing Initiated for Sixth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

Oncternal Therapeutics to Present in JonesTrading Healthcare Summit

GlobeNewswire

4 months ago

Oncternal Therapeutics to Present in JonesTrading Healthcare Summit

Edge Total Intelligence Inc. Updates Status of MCTO

Newsfile

5 months ago

Edge Total Intelligence Inc. Updates Status of MCTO

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

CNW Group

5 months ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

GlobeNewswire

5 months ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

GlobeNewswire

5 months ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

GlobeNewswire

5 months ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

GlobeNewswire

5 months ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

5 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

5 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

5 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

5 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

5 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

5 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

5 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

5 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

5 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

5 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire

6 months ago

Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results

Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire

7 months ago

Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

Oncternal Participating in Virtual Fireside Chat with Key Opinion Leader on Treatment Landscape & New Treatment Options for Prostate Cancer

GlobeNewswire

8 months ago

Oncternal Participating in Virtual Fireside Chat with Key Opinion Leader on Treatment Landscape & New Treatment Options for Prostate Cancer

Oncternal Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.

8 months ago

Oncternal Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

8 months ago

Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

9 months ago

Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results

Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

9 months ago

Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference

Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

9 months ago

Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

AppTech Payments Announces Strategic Partnership with First Inning Ventures to Expand Commerse™ Suite in the International and Domestic Sports Market

GlobeNewswire

10 months ago

AppTech Payments Announces Strategic Partnership with First Inning Ventures to Expand Commerse™ Suite in the International and Domestic Sports Market

Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million

GlobeNewswire

10 months ago

Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million

DayDayCook Provides Financial Update and Corporate Highlights

GlobeNewswire

10 months ago

DayDayCook Provides Financial Update and Corporate Highlights

LINKBANCORP, Inc.'s (NASDAQ:LNKB) largest shareholders are individual investors with 49% ownership, insiders own 30%

Simply Wall St.

10 months ago

LINKBANCORP, Inc.'s (NASDAQ:LNKB) largest shareholders are individual investors with 49% ownership, insiders own 30%

FAT Brands Inc. Announces First Quarter Cash Dividend on Class A Common Stock and Class B Common Stock

GlobeNewswire

10 months ago

FAT Brands Inc. Announces First Quarter Cash Dividend on Class A Common Stock and Class B Common Stock

Altitude Acquisition Corp. Announces Extension of Deadline to Complete Initial Business Combination

GlobeNewswire

10 months ago

Altitude Acquisition Corp. Announces Extension of Deadline to Complete Initial Business Combination

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense

GlobeNewswire

10 months ago

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense

Independent Research Finds 100% Accuracy for Intellicheck Identity Validation Technology

Business Wire

10 months ago

Independent Research Finds 100% Accuracy for Intellicheck Identity Validation Technology

Smart Wearables Leader Zepp Health Unveils the Amazfit Helio Ring for Optimum Athletic Performance at CES 2024

Business Wire

10 months ago

Smart Wearables Leader Zepp Health Unveils the Amazfit Helio Ring for Optimum Athletic Performance at CES 2024

Oncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire

10 months ago

Oncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer

GlobeNewswire

10 months ago

SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer

Oncternal Therapeutics Announces Reverse Stock Split

GlobeNewswire

10 months ago

Oncternal Therapeutics Announces Reverse Stock Split

Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024

Business Wire

10 months ago

Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024

Sono-Tek Completes Senior Management Transition

GlobeNewswire

10 months ago

Sono-Tek Completes Senior Management Transition

25 Best Online Degree Programs For Working Adults

Insider Monkey

a year ago

25 Best Online Degree Programs For Working Adults

$Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma$

GlobeNewswire

a year ago

Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma

Prairie Operating Co. Announces Uplisting to The Nasdaq Capital Market

GlobeNewswire

a year ago

Prairie Operating Co. Announces Uplisting to The Nasdaq Capital Market

InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System

GlobeNewswire

a year ago

InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System

Zedge, Inc. (AMEX:ZDGE) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Zedge, Inc. (AMEX:ZDGE) Q1 2024 Earnings Call Transcript

CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Price Is Right But Growth Is Lacking After Shares Rocket 33%

Simply Wall St.

a year ago

CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Price Is Right But Growth Is Lacking After Shares Rocket 33%

Reneo (RPHM) Plummets 83% on Failure of Metabolic Disorder Study

Zacks

a year ago

Reneo (RPHM) Plummets 83% on Failure of Metabolic Disorder Study

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)

GlobeNewswire

a year ago

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)

1895 BANCORP OF WISCONSIN, INC. ANNOUNCES BALANCE SHEET REPOSITIONING

PR Newswire

a year ago

1895 BANCORP OF WISCONSIN, INC. ANNOUNCES BALANCE SHEET REPOSITIONING

Epsilon Energy (NASDAQ:EPSN) Is Paying Out A Dividend Of $0.0625

Simply Wall St.

a year ago

Epsilon Energy (NASDAQ:EPSN) Is Paying Out A Dividend Of $0.0625

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

GlobeNewswire

a year ago

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

Epsilon Energy Ltd.'s (NASDAQ:EPSN) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Simply Wall St.

a year ago

Epsilon Energy Ltd.'s (NASDAQ:EPSN) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

GOLDMINING TO ADVANCE THE REA URANIUM PROJECT, ONE OF THE LARGEST LAND PACKAGES IN WESTERN ATHABASCA BASIN, CANADA

PR Newswire

a year ago

GOLDMINING TO ADVANCE THE REA URANIUM PROJECT, ONE OF THE LARGEST LAND PACKAGES IN WESTERN ATHABASCA BASIN, CANADA

PR Newswire

a year ago

JOHN HANCOCK CLOSED-END FUNDS DECLARE QUARTERLY DISTRIBUTIONS

Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit

GlobeNewswire

a year ago

Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit

Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide

GlobeNewswire

a year ago

Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide

President of Epsilon Energy Picks Up 13% More Stock

Simply Wall St.

a year ago

President of Epsilon Energy Picks Up 13% More Stock

PR Newswire

a year ago

JOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATA

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2023 Earnings Call Transcript

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board

Business Wire

a year ago

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board

Rezolute Reports First Quarter Fiscal 2024 Results

GlobeNewswire

a year ago

Rezolute Reports First Quarter Fiscal 2024 Results

Espey Mfg. & Electronics Corp. reports first quarter results

GlobeNewswire

a year ago

Espey Mfg. & Electronics Corp. reports first quarter results

Drilling Tools International Reports Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Drilling Tools International Reports Third Quarter 2023 Financial Results

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript

Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

Cue Health Inc. (NASDAQ:HLTH) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Cue Health Inc. (NASDAQ:HLTH) Q3 2023 Earnings Call Transcript

3 Top Penny Stocks to Make You a Millionaire in 5 Years

InvestorPlace

a year ago

3 Top Penny Stocks to Make You a Millionaire in 5 Years

Share on Social Networks: